Carbapenem-resistant Enterobacteriaceae (CRE) are a growing problem in the United States. We explored the feasibility of active laboratory-based surveillance of CRE in a metropolitan area not previously considered to be an area of CRE endemicity. We provide a framework to address CRE surveillance and to monitor changes in the incidence of CRE infection over time.
|Original language||English (US)|
|Number of pages||3|
|Journal||Infection Control and Hospital Epidemiology|
|State||Published - 2014|